Philipp VON LATTORFF Chief Executive Officer, Boehringer Ingelheim RCV GmbH & Co KG, Vienna
CV
| 1986-1991 | Master in Business Administration, Management School of Barcelona |
| 1991-1993 | Finance/Controlling Department, IBM Austria, Vienna |
| 1993-1994 | Assistant, Regional Manager CEE, Boehringer Ingelheim, Vienna |
| 1994-1996 | Regional Manager Baltic States, Boehringer Ingelheim, Tallinn |
| 1997-1999 | General Manager BI Hungary, Boehringer Ingelheim, Budapest |
| 1999-2001 | Assistant, Area Management Europe, Boehringer Ingelheim, |
| 2001-2002 | Team Member, global launch TEAM Spiriva, Boehringer Ingelheim |
| 2002-2004 | Head, M&S CEE, Boeringer Ingelheim, Vienna |
| 2004-2008 | Head, M&S Italy, Boehringer Ingelheim Italy, Milan |
| 2008-2011 | General Manager, Angelini Pharma CEE, Bisamberg/Vienna |
| 2011-2013 | Head, Corporate PM / CHC Prescription Medicines Emerging Markets, Boehringer Ingelheim |
| since 2013 | CEO, Regional Center Vienna, Boehringer Ingelheim RCV GmbH & Co KG |
Mitgliedschaften
| Board Member of the Pharmig (Association of Pharmaceutical Industry Austria), since 2013 | |
| Chairman of Supervisory Board / Institute for Molecular Pathology, since 2013 | |
| Vice Chairman of Professional Group Pharmaceutical Industrie / Association of the Austrian Chemical Industry (FCIO), since 2016 | |
| Vice President of the Pharmig (Association of Pharmaceutical Industry Austria), since 2017 |
